Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors - PubMed (original) (raw)
. 1999 Jun 1;59(11):2570-6.
Affiliations
- PMID: 10363975
Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors
E Llano et al. Cancer Res. 1999.
Abstract
A cDNA encoding a new member of the membrane-type (MT) matrix metalloproteinase (MMP) family has been identified and cloned from a human brain cDNA library. The isolated cDNA encodes a polypeptide of 645 amino acids that displays a similar domain organization as other MMPs, including a predomain with the activation locus, a zinc-binding site, and a hemopexin domain. The deduced amino acid sequence contains a COOH-terminal extension, rich in hydrophobic residues and similar in size to the equivalent domains identified in MT-MMPs. Immunofluorescence and Western blot analysis of COS-7 cells transfected with the isolated cDNA revealed that the encoded protein is localized in the plasma membrane. On the basis of these features, this novel human MMP has been called MT5-MMP because it represents the fifth member of the MT-MMP subfamily of MMPs. Fluorescent in situ hybridization experiments showed that the human MT5-MMP gene (MMP-24) maps to 20q11.2, a region frequently amplified in tumors from diverse sources. Northern blot analysis demonstrated that MT5-MMP is predominantly expressed in brain, kidney, pancreas, and lung. In addition, MT5-MMP transcripts were detected at high levels compared to normal brain tissue in a series of brain tumors, including astrocytomas and glioblastomas. The catalytic domain of MT5-MMP, produced in Escherichia coli as a fusion protein with glutathione S-transferase, exhibits a potent proteolytic activity against progelatinase A, leading to the generation of the Mr 62,000 active form of this enzyme. These data suggest that MT5-MMP may contribute to the activation of progelatinase A in tumor tissues, in which it is overexpressed, thereby facilitating tumor progression.
Similar articles
- Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G, Cal S, Merlos-Suárez A, Ferrando AA, Alvarez S, Nakano A, Arribas J, López-Otín C. Velasco G, et al. Cancer Res. 2000 Feb 15;60(4):877-82. Cancer Res. 2000. PMID: 10706098 - Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.
Puente XS, Pendás AM, Llano E, Velasco G, López-Otín C. Puente XS, et al. Cancer Res. 1996 Mar 1;56(5):944-9. Cancer Res. 1996. PMID: 8640782 - Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS. Yamamoto M, et al. Cancer Res. 1996 Jan 15;56(2):384-92. Cancer Res. 1996. PMID: 8542596 - Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H, Okada Y, Seiki M. Sato H, et al. Thromb Haemost. 1997 Jul;78(1):497-500. Thromb Haemost. 1997. PMID: 9198203 Review. - Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
Fillmore HL, VanMeter TE, Broaddus WC. Fillmore HL, et al. J Neurooncol. 2001 Jun;53(2):187-202. doi: 10.1023/a:1012213604731. J Neurooncol. 2001. PMID: 11716070 Review.
Cited by
- Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules.
Wang X, Zhang Z, Cao X. Wang X, et al. Cancer Biol Ther. 2024 Dec 31;25(1):2322206. doi: 10.1080/15384047.2024.2322206. Epub 2024 Mar 4. Cancer Biol Ther. 2024. PMID: 38436092 Free PMC article. - The roles of intracellular proteolysis in cardiac ischemia-reperfusion injury.
Hartley B, Bassiouni W, Schulz R, Julien O. Hartley B, et al. Basic Res Cardiol. 2023 Sep 28;118(1):38. doi: 10.1007/s00395-023-01007-z. Basic Res Cardiol. 2023. PMID: 37768438 Review. - The multifaceted roles of matrix metalloproteinases in lung cancer.
Wei C. Wei C. Front Oncol. 2023 Sep 12;13:1195426. doi: 10.3389/fonc.2023.1195426. eCollection 2023. Front Oncol. 2023. PMID: 37766868 Free PMC article. Review. - Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease.
Molière S, Jaulin A, Tomasetto CL, Dali-Youcef N. Molière S, et al. Int J Mol Sci. 2023 Jun 26;24(13):10649. doi: 10.3390/ijms241310649. Int J Mol Sci. 2023. PMID: 37445827 Free PMC article. Review. - Matrix metalloproteinase profiling and their roles in disease.
Chang M. Chang M. RSC Adv. 2023 Feb 21;13(9):6304-6316. doi: 10.1039/d2ra07005g. eCollection 2023 Feb 14. RSC Adv. 2023. PMID: 36825288 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases